Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.

By L. Cohen, C. Soares, A. Vitonis, M. Otto, B. Harlow. Archives of General Psychiatry, 2006

794 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The 2012 Hormone Therapy Position Statement of The North American Menopause Society (2012, neutral): “It is controversial whether ET might, in some circumstances, augment the antidepressant effects of selective serotonin reuptake inhibitors.(130,131)”
Understanding the impact of sex and gender in Alzheimer's disease: A call to action (2018, neutral): “[26] Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL.”
Sex differences in anxiety and depression clinical perspectives (2014, background): “Importantly, the risk for major depression appears to decline in the years postmenopause such that there are no longer sex differences in risks for major depression (Cohen et al., 2006; Freeman et al., 2014).”
Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods (2015, background): “…depressive symptoms (disruption of sleep and appetite) are unavoidable during pregnancy and postpartum (Marcus, 2009), and that there may be a distinct pattern of reactivity in women who have never had a depressive episode before, vs. women who are already at risk (Cohen et al., 2004, 2006b).”